Medicure Inc announced that the FDA has granted full approval to enroll patients in its pivotal phase 3 clinical trial to evaluate the use of its investigational product MC-1 for the treatment of pyridox(am)ine 5'-phosphate oxidase (PNPO)...
A new active pharmaceutical ingredient (API) factory was opened by the pharmaceutical business Rusan Pharma. With an annual production capacity of 400 metric tons of APIs, this plant is estimated to generate over 300 employment. The factory is...
Following the approval of bevacizumab for the treatment of metastatic colorectal cancer, Pune-based Enzene Biosciences has now launched ranibizumab, a biosimilar of the originator medication Lucentis, which is sold in India under the brand name...
DTx can be utilized independently or along with conventional treatments such as medication, face-to-face therapy, as well as various hardware, sensory, or mechanical devices.
Simcere Pharmaceutical Group Limited (Simcere) and Connect Biopharma HongKong Limited (Connect) have entered into an exclusive licensing and partnership agreement for Rademikibart, a novel IL-4Ra monoclonal antibody. Pursuant to the Agreement...
Bracco announced a new long-term agreement that would deliver a Bracco-branded cutting-edge MR injector to the United States under an exclusive private label agreement. The two companies also announced the submission of a 510(k) premarket...
Strides Pharma Science's step-down fully owned subsidiary, Strides Pharma Global Pte. Singapore, has acquired FDA clearance for sodium sulphate, potassium sulphate, and magnesium sulphate oral solution 17.5g/ 3.13g/ 1.6g per 6 ounces (product)...
As per joint EY Parthenon-Organisation of Pharmaceutical Producers of India (OPPI) report, the Indian pharmaceutical industry can grow to $450 billion by 2047 as a result of transformative innovation, fortification of manufacturing and quality...
Sanjivani Paranteral Limited, a prominent pharmaceutical firm specializing in the production and sale of high-quality parenteral and oral solid products, has entered into a substantial deal with Hindustan Antibiotics Limited for the production of...
Simcere Pharmaceutical Group Limited signed into an exclusive licensing and partnership agreement with Connect Biopharma HongKong Limited In respect to Rademikibart, a novel IL-4R monoclonal antibody. Pursuant to the Agreement, Simcere obtains...
, CDSCO.jpg)
